As of 2026-06-11, the Fair Value of PYC Therapeutics Ltd (PYC.AX) is -0.24 AUD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.16 AUD, the upside of PYC Therapeutics Ltd is -120.84%.
With the market price of 1.16 AUD and our fair value calculation, PYC Therapeutics Ltd (PYC.AX) is not a good investment. Investing in PYC.AX stocks now will result in a potential loss of 120.84%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | 5Y Avg | |
| Net income | -17.77 | -13.86 | -22.79 | -37.73 | -50.30 | -28.49 |
| YoY growth | -160.44% | 21.98% | -64.39% | -65.54% | -33.34% | -60.35% |
| Market Cap (mil) | 1,140.87 |
| P/E | |
| Forward P/E |
| EPS | -0.05 |
| Avg earnings growth rate | -60.35% |
| TTM earnings | -47.56 |